re e-tender for procurement of some drug items under table-a, for two years from the date of aoc , adenosine inj. u.s.p. 3 mg / ml in 2 ml. , clozapine tab.50 mg , dabigatran etexilate mesylate cap. 110 mg , dextrose solution i.p. 5% (blow fill & seal process) , finasteride tab 5mg , insulin (human pre mixed )soluble & nph combination (30 : 70) or (25:75)/ i.u.-in vial(maximum pack size allowed 10ml /vial) , insulin glargine (rdna 100 i.u./ml) -in vial / pfs/ cartridge , insulin soluble inj. i.p.40 i.u. / ml in 10 ml vial . , levothyroxine sodium tab 100 mcg , levothyroxine sodium tab 50 mcg , methotrexate tab 15 mg , oseltamivir syrup ip (oseltamivir phosphate) 12 mg/ml, 75 ml phial , snake anti venom serum i.p.liquid (10ml) neutralizing venoms of cobra, common krait, russells viper, saw scaled viper. , triptorelin 11.25 mg la inj , zidovudine 60 mg + lamivudine 30mg tabs , important note: 1. all prospective bidders are requested to quote the rate in boq as per accounting unit & item specification as mentioned in the table-a. wrong quoting of the rate in boq will be dealt with as per penal provisions of the t&c of the tender. 2. quality of the product supplied, may be ascertained by testing / physical examination by the experts at any stage of the tender period. 3. the prospective bidders of the said tender are requested to make a declaration in affidavit under annexure vi(b)in case of sole manufacturer/importer (i.e. proprietary in nature). 4. if the item(s) under sole manufacturer / importer is (are) proprietary in nature, quarterly intimation is solicited from the approved bidders positively regarding the status of their item(s) proprietary in nature, otherwise their item(s) will be blocked in the smis. 5. in case of tie bid, decision will be taken by the tia as per g.o. no. 2320-f(y), dated 07.06.2022 issued from finance department audit branch (group t).